Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204220 | SCV000261999 | benign | Atrioventricular septal defect 4 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000618306 | SCV000736147 | benign | Cardiovascular phenotype | 2017-09-12 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001556769 | SCV001778406 | likely benign | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001556769 | SCV003799771 | benign | not provided | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001795341 | SCV002034276 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001556769 | SCV002036347 | likely benign | not provided | no assertion criteria provided | clinical testing |